Nifty

:

26042.30

Sensex

:

85041.45

-99.80 (-0.38%)
-367.25 (-0.43%)

Login

Nifty
Sensex

:
:

26042.30
85041.45

-99.80 (-0.38%)
-367.25 (-0.43%)

JB Chemicals & Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

65/99

BSE: 506943 | NSE: JBCHEPHARM

Watchlist

NSE BSE

1818.60

26-Dec-2025

Open
High
Low
Previous Close

1827.5
1827.5
1801.7
1815.50

Volume
Traded Value (lacs)
52 Week High
52 Week Low

173611
315222433.1
1918.5
1385.75

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

28,462.70
39.62
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

28,365.70
0.85%
7.48

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

12.27
13.91
7.55

EBITDA CAGR (%)

10 Years
5 Years
3 Years

17.47
13.14
8.19

PAT CAGR (%)

10 Years
5 Years
3 Years

15.13
8.05
17.19

P:E (Median)

8 Years
5 Years
3 Years

30.25
39.27
44.81

P:BV (Average)

8 Years
5 Years
3 Years

5.63
7.47
8.22

EV:EBITDA (Average)

8 Years
5 Years
3 Years

19.15
24.20
26.87

Earnings Forecasts:

(Updated: 20-12-2025)

Description 2024 2025 2026 2027
Adj EPS 42.45 51.05 60.5 72.56
P/E Ratio 42.84 35.62 30.06 25.06
Revenue 3867.12 4336.56 4852.28 5410.31
EBITDA 1031.12 1189.24 1381.26 1640.91
Net Income 659.58 799.91 946.15 1136.33
ROA 15.96
P/B Ratio 8.25 7.05 5.99 5.11
ROE 20.75 21.49 21.62 22.16
FCFF 799.79 688.4 202.08 1115.92
FCFF Yield 2.89 2.48 0.73 4.03
Net Debt -418.67 -1262.6 -955.7 -1639.3
BVPS 220.54 258.04 303.66 356.13

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var%
Net Sales 1,022.65 955.76 7.00% 1,039.90 952.31 9.20% 901.34 809.20 11.39% 913.51 800.10 14.17%
Expenses 724.29 687.58 5.34% 746.78 678.93 9.99% 670.36 614.15 9.15% 668.11 585.41 14.13%
EBITDA 298.36 268.18 11.25% 293.12 273.38 7.22% 230.98 195.05 18.42% 245.40 214.69 14.30%
EBIDTM 29.18% 28.06% 28.19% 28.71% 25.63% 24.10% 26.86% 26.83%
Other Income 14.25 8.89 60.29% 13.90 5.16 169.38% 13.53 16.10 -15.96% 7.16 6.61 8.32%
Interest 1.01 2.02 -50.00% 0.66 4.32 -84.72% 0.93 8.32 -88.82% 1.85 11.52 -83.94%
Depreciation 43.11 40.85 5.53% 41.40 40.01 3.47% 44.41 39.72 11.81% 41.18 33.37 23.40%
PBT 268.49 234.20 14.64% 264.96 234.21 13.13% 199.17 163.11 22.11% 209.53 176.41 18.77%
Tax 68.07 61.08 11.44% 67.09 60.98 10.02% 49.37 37.26 32.50% 53.14 48.49 9.59%
PAT 200.42 173.12 15.77% 197.87 173.23 14.22% 149.80 125.85 19.03% 156.39 127.92 22.26%
PATM 19.60% 18.11% 19.03% 18.19% 16.62% 15.55% 17.12% 15.99%
EPS 12.80 11.05 15.84% 12.64 11.06 14.29% 9.57 8.04 19.03% 9.99 8.17 22.28%

Description Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var%
Net Sales 1,084.90 1,000.62 8.42% 1,093.94 1,004.40 8.91% 949.48 861.73 10.18% 963.49 844.51 14.09%
Expenses 775.30 730.10 6.19% 793.07 724.03 9.54% 723.04 663.61 8.96% 708.98 621.39 14.10%
EBITDA 309.60 270.52 14.45% 300.87 280.37 7.31% 226.44 198.12 14.29% 254.51 223.12 14.07%
EBIDTM 28.54% 27.04% 27.50% 27.91% 23.85% 22.99% 26.42% 26.42%
Other Income 15.34 9.95 54.17% 14.55 5.89 147.03% 14.48 16.63 -12.93% 8.00 7.35 8.84%
Interest 1.35 2.06 -34.47% 1.11 5.64 -80.32% 1.45 9.41 -84.59% 2.58 12.49 -79.34%
Depreciation 44.44 41.88 6.11% 42.70 40.78 4.71% 46.44 40.74 13.99% 41.94 34.03 23.24%
PBT 279.15 236.53 18.02% 271.61 239.84 13.25% 193.03 164.60 17.27% 217.99 183.95 18.51%
Tax 71.33 61.96 15.12% 69.23 63.01 9.87% 47.34 38.44 23.15% 55.50 50.38 10.16%
PAT 207.82 174.57 19.05% 202.38 176.83 14.45% 145.69 126.16 15.48% 162.49 133.57 21.65%
PATM 19.16% 17.45% 18.50% 17.61% 15.34% 14.64% 16.86% 15.82%
EPS 13.27 11.24 18.06% 12.96 11.39 13.78% 9.36 8.13 15.13% 10.45 8.62 21.23%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 3,877.40 3,722.92 3,298.64 2,884.16 2,189.88 1,892.00 1,640.74 1,501.19 1,254.99 1,198.69 1,164.94 Net Sales Growth 10.24% 12.86% 14.37% 31.70% 15.74% 15.31% 9.30% 19.62% 4.70% 2.90% Cost Of Goods Sold 1,261.75 1,252.22 1,109.07 1,036.73 743.70 625.76 569.14 536.35 484.27 469.32 470.01 Gross Profit 2,615.65 2,470.69 2,189.57 1,847.44 1,446.18 1,266.24 1,071.61 964.83 770.72 729.38 694.93 GP Margin 67.46% 66.36% 66.38% 64.05% 66.04% 66.93% 65.31% 64.27% 61.41% 60.85% 59.65% Total Expenditure 2,809.54 2,707.65 2,421.57 2,219.47 1,681.15 1,339.66 1,272.50 1,212.75 1,072.79 980.15 939.21 Power & Fuel Cost - 83.83 87.95 91.44 71.36 62.60 61.54 63.29 58.28 54.89 55.28 % Of Sales - 2.25% 2.67% 3.17% 3.26% 3.31% 3.75% 4.22% 4.64% 4.58% 4.75% Employee Cost - 646.79 565.38 499.95 399.06 305.98 293.78 257.98 217.31 187.86 165.96 % Of Sales - 17.37% 17.14% 17.33% 18.22% 16.17% 17.91% 17.19% 17.32% 15.67% 14.25% Manufacturing Exp. - 267.03 219.93 200.49 176.57 134.52 129.40 139.89 130.97 122.68 119.24 % Of Sales - 7.17% 6.67% 6.95% 8.06% 7.11% 7.89% 9.32% 10.44% 10.23% 10.24% General & Admin Exp. - 118.90 111.97 103.42 93.33 54.90 46.11 49.84 49.82 39.08 32.06 % Of Sales - 3.19% 3.39% 3.59% 4.26% 2.90% 2.81% 3.32% 3.97% 3.26% 2.75% Selling & Distn. Exp. - 249.28 235.96 197.12 133.38 99.94 106.58 104.91 59.44 48.83 48.13 % Of Sales - 6.70% 7.15% 6.83% 6.09% 5.28% 6.50% 6.99% 4.74% 4.07% 4.13% Miscellaneous Exp. - 89.58 91.30 90.33 63.76 55.96 65.96 60.48 72.71 57.49 48.13 % Of Sales - 2.41% 2.77% 3.13% 2.91% 2.96% 4.02% 4.03% 5.79% 4.80% 4.17% EBITDA 1,067.86 1,015.27 877.07 664.69 508.73 552.34 368.24 288.44 182.20 218.54 225.73 EBITDA Margin 27.54% 27.27% 26.59% 23.05% 23.23% 29.19% 22.44% 19.21% 14.52% 18.23% 19.38% Other Income 48.84 37.40 37.02 8.65 38.80 115.92 49.57 40.23 56.21 49.51 55.68 Interest 4.45 9.12 40.52 34.31 4.95 7.19 3.16 4.57 3.41 5.00 10.29 Depreciation 170.10 166.45 135.24 111.99 71.28 67.36 65.09 54.82 55.95 46.26 40.41 PBT 942.15 877.11 738.34 527.04 471.29 593.71 349.56 269.28 179.04 216.78 230.69 Tax 237.67 224.56 194.98 138.15 110.29 146.62 71.42 87.22 51.04 43.82 51.49 Tax Rate 25.23% 25.60% 26.41% 26.21% 23.40% 24.70% 21.03% 32.39% 28.51% 20.21% 22.32% PAT 704.48 652.54 543.36 388.89 361.00 447.08 268.14 182.06 128.00 172.96 179.20 PAT before Minority Interest 704.48 652.54 543.36 388.89 361.00 447.08 268.14 182.06 128.00 172.96 179.20 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 18.17% 17.53% 16.47% 13.48% 16.48% 23.63% 16.34% 12.13% 10.20% 14.43% 15.38% PAT Growth 17.39% 20.09% 39.72% 7.73% -19.25% 66.73% 47.28% 42.23% -25.99% -3.48% EPS 44.99 41.67 34.70 24.83 23.05 28.55 17.12 11.63 8.17 11.04 11.44

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 4,091.81 3,917.99 3,484.18 3,149.28 2,424.24 2,042.52 1,774.73 1,643.20 1,413.77 1,368.32 1,231.58 Net Sales Growth 10.25% 12.45% 10.63% 29.91% 18.69% 15.09% 8.00% 16.23% 3.32% 11.10% Cost Of Goods Sold 1,330.97 1,316.54 1,182.05 1,168.20 842.93 701.50 630.80 596.46 542.41 552.00 491.41 Gross Profit 2,760.84 2,601.44 2,302.13 1,981.08 1,581.31 1,341.02 1,143.93 1,046.74 871.35 816.32 740.17 GP Margin 67.47% 66.40% 66.07% 62.91% 65.23% 65.66% 64.46% 63.70% 61.63% 59.66% 60.10% Total Expenditure 3,000.39 2,886.87 2,591.70 2,453.53 1,881.63 1,486.35 1,397.15 1,337.36 1,214.64 1,135.93 1,025.55 Power & Fuel Cost - 83.95 88.08 91.54 71.47 62.60 61.54 63.29 58.28 54.89 55.28 % Of Sales - 2.14% 2.53% 2.91% 2.95% 3.06% 3.47% 3.85% 4.12% 4.01% 4.49% Employee Cost - 687.61 601.41 543.45 439.24 340.60 322.92 288.18 251.10 217.34 175.31 % Of Sales - 17.55% 17.26% 17.26% 18.12% 16.68% 18.20% 17.54% 17.76% 15.88% 14.23% Manufacturing Exp. - 286.95 234.82 210.91 194.00 148.68 140.70 150.49 139.83 131.45 119.35 % Of Sales - 7.32% 6.74% 6.70% 8.00% 7.28% 7.93% 9.16% 9.89% 9.61% 9.69% General & Admin Exp. - 127.18 119.69 110.09 100.46 56.35 48.14 52.97 53.96 42.26 34.82 % Of Sales - 3.25% 3.44% 3.50% 4.14% 2.76% 2.71% 3.22% 3.82% 3.09% 2.83% Selling & Distn. Exp. - 288.65 268.40 233.96 161.80 113.22 116.95 113.59 87.44 78.27 72.72 % Of Sales - 7.37% 7.70% 7.43% 6.67% 5.54% 6.59% 6.91% 6.18% 5.72% 5.90% Miscellaneous Exp. - 95.98 97.24 95.38 71.72 63.38 76.11 72.38 81.61 59.72 72.72 % Of Sales - 2.45% 2.79% 3.03% 2.96% 3.10% 4.29% 4.40% 5.77% 4.36% 6.22% EBITDA 1,091.42 1,031.12 892.48 695.75 542.61 556.17 377.58 305.84 199.13 232.39 206.03 EBITDA Margin 26.67% 26.32% 25.62% 22.09% 22.38% 27.23% 21.28% 18.61% 14.09% 16.98% 16.73% Other Income 52.37 39.04 41.67 9.94 40.07 116.62 50.90 41.44 55.29 50.16 56.65 Interest 6.49 11.73 44.33 36.05 5.12 7.24 3.26 4.65 3.49 5.37 10.65 Depreciation 175.52 171.04 138.32 114.41 72.66 68.67 66.32 55.64 56.97 47.22 41.22 PBT 961.78 887.39 751.51 555.23 504.90 596.89 358.89 286.99 193.95 229.94 210.82 Tax 243.40 227.81 198.88 145.23 118.86 148.36 76.50 93.02 55.23 45.55 49.58 Tax Rate 25.31% 25.67% 26.46% 26.16% 23.54% 24.86% 21.93% 32.41% 28.48% 19.81% 23.52% PAT 718.38 659.58 552.63 409.84 385.36 447.96 272.04 193.47 138.34 184.06 161.14 PAT before Minority Interest 718.38 659.58 552.63 410.01 386.04 448.52 272.39 193.97 138.72 184.40 161.24 Minority Interest 0.00 0.00 0.00 -0.17 -0.68 -0.56 -0.35 -0.50 -0.38 -0.34 -0.10 PAT Margin 17.56% 16.83% 15.86% 13.01% 15.90% 21.93% 15.33% 11.77% 9.79% 13.45% 13.08% PAT Growth 17.55% 19.35% 34.84% 6.35% -13.97% 64.67% 40.61% 39.85% -24.84% 14.22% EPS 45.87 42.12 35.29 26.17 24.61 28.61 17.37 12.35 8.83 11.75 10.29

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 3,377.19 2,886.26 2,442.48 2,103.67 1,806.46 1,445.29 1,484.56 1,453.39 1,387.86 1,222.71 Share Capital 15.57 15.52 15.48 15.46 15.46 15.46 16.05 16.71 16.96 16.96 Total Reserves 3,193.60 2,730.90 2,305.38 2,025.56 1,791.00 1,429.83 1,468.52 1,436.67 1,370.90 1,205.74 Non-Current Liabilities 459.79 475.43 993.50 476.54 86.41 73.29 79.08 62.98 41.79 46.07 Secured Loans 0.00 23.64 383.22 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 265.72 287.44 488.47 402.70 12.57 7.39 5.73 9.67 8.88 10.20 Current Liabilities 1,101.40 1,235.44 579.28 418.54 645.74 493.55 763.27 711.89 666.97 735.89 Trade Payables 384.58 331.65 221.71 196.24 164.02 151.88 111.33 100.22 79.03 68.61 Other Current Liabilities 133.21 431.04 236.31 77.46 86.45 100.73 87.05 112.90 118.08 119.03 Short Term Borrowings 0.00 0.00 6.71 26.32 26.43 29.49 25.80 28.48 48.86 174.40 Short Term Provisions 583.61 472.74 114.55 118.52 368.83 211.45 539.10 470.29 421.00 373.85 Total Liabilities 4,938.38 4,597.13 4,015.26 2,998.75 2,538.61 2,012.13 2,326.91 2,228.26 2,096.62 2,004.67 Net Block 1,883.29 1,925.42 1,821.66 1,203.67 564.60 583.21 552.11 569.91 608.69 369.35 Gross Block 2,867.77 2,749.15 2,522.18 1,796.83 1,108.14 1,105.15 1,011.81 979.68 963.76 679.77 Accumulated Depreciation 984.48 823.73 700.52 593.16 543.54 521.95 459.70 409.78 355.07 310.42 Non Current Assets 2,642.77 2,467.36 2,545.71 1,796.70 742.49 805.74 804.94 781.26 941.36 891.59 Capital Work in Progress 61.70 76.06 55.15 18.68 25.57 16.17 15.09 17.40 3.76 134.89 Non Current Investment 170.86 166.58 146.75 145.69 145.88 202.42 228.84 182.92 318.81 364.38 Long Term Loans & Adv. 275.94 293.26 507.64 427.63 5.62 3.59 8.31 10.00 9.22 22.63 Other Non Current Assets 250.98 6.03 14.51 1.04 0.82 0.36 0.59 1.03 0.88 0.33 Current Assets 2,295.62 2,129.78 1,469.56 1,202.05 1,796.12 1,206.39 1,521.97 1,446.99 1,155.26 1,113.08 Current Investments 317.11 364.65 192.18 0.00 664.97 333.81 360.65 383.77 224.96 247.28 Inventories 471.64 461.20 386.95 349.78 278.91 232.04 208.10 175.81 159.96 133.29 Sundry Debtors 768.09 624.78 523.58 518.05 374.11 344.24 299.85 300.54 265.10 265.67 Cash & Bank 90.57 63.70 55.76 39.67 26.43 11.56 20.77 14.95 7.20 10.71 Other Current Assets 648.22 34.38 39.23 55.77 451.70 284.74 632.60 571.92 498.05 456.13 Short Term Loans & Adv. 615.26 581.07 271.85 238.77 408.10 266.71 600.11 560.72 485.82 453.62 Net Current Assets 1,194.22 894.34 890.27 783.51 1,150.38 712.84 758.71 735.10 488.29 377.19 Total Assets 4,938.39 4,597.14 4,015.27 2,998.75 2,538.61 2,012.13 2,326.91 2,228.25 2,096.62 2,004.67

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 3,433.32 2,923.33 2,480.35 2,134.12 1,809.72 1,435.49 1,480.12 1,441.56 1,363.67 1,183.84 Share Capital 15.57 15.52 15.48 15.46 15.46 15.46 16.05 16.71 16.96 16.96 Total Reserves 3,249.72 2,767.97 2,343.26 2,056.01 1,794.27 1,420.03 1,464.08 1,424.84 1,346.70 1,166.87 Non-Current Liabilities 443.23 465.96 992.03 475.34 72.47 62.72 64.84 45.66 26.98 31.02 Secured Loans 0.00 23.64 383.22 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 266.06 287.66 494.68 410.43 12.57 7.39 5.73 9.67 12.56 10.43 Current Liabilities 1,156.93 1,287.76 625.70 455.16 686.57 516.19 781.54 736.50 693.46 797.22 Trade Payables 410.72 356.31 238.65 224.48 186.92 167.97 117.37 110.39 98.98 90.85 Other Current Liabilities 137.33 435.75 240.33 81.31 89.82 102.67 93.10 119.75 122.15 138.73 Short Term Borrowings 13.80 15.34 28.02 26.32 32.64 29.49 25.80 29.29 48.86 193.02 Short Term Provisions 595.08 480.35 118.71 123.06 377.17 216.06 545.27 477.06 423.47 374.61 Total Liabilities 5,033.48 4,677.05 4,098.08 3,069.11 2,572.47 2,016.90 2,329.30 2,226.49 2,086.29 2,013.75 Net Block 1,968.19 2,004.40 1,901.01 1,276.99 633.65 651.26 620.93 639.50 679.44 440.22 Gross Block 2,964.52 2,835.23 2,607.77 1,876.20 1,182.55 1,177.43 1,084.83 1,053.76 1,038.55 753.75 Accumulated Depreciation 996.33 830.83 706.76 599.21 548.90 526.17 463.89 414.25 359.10 313.53 Non Current Assets 2,586.15 2,404.17 2,498.80 1,744.51 678.57 740.83 740.80 717.89 879.15 831.58 Capital Work in Progress 63.05 76.40 55.15 18.68 25.57 16.17 15.09 17.40 3.76 134.89 Non Current Investment 27.98 23.71 13.78 12.72 12.91 69.45 95.88 49.96 185.84 231.42 Long Term Loans & Adv. 275.94 293.64 514.35 435.07 5.62 3.59 8.31 10.15 9.43 22.63 Other Non Current Assets 250.98 6.03 14.51 1.04 0.82 0.36 0.59 0.88 0.67 2.43 Current Assets 2,447.33 2,272.87 1,599.29 1,324.61 1,893.89 1,276.08 1,588.51 1,508.59 1,207.14 1,182.16 Current Investments 317.11 364.65 192.18 0.00 664.97 333.81 360.65 383.77 224.96 247.28 Inventories 528.96 502.51 430.48 409.96 347.45 274.67 243.76 213.73 200.17 187.98 Sundry Debtors 815.38 686.92 575.80 555.69 389.02 345.43 308.22 300.73 265.97 272.64 Cash & Bank 129.45 95.54 78.81 58.53 30.85 30.95 36.80 29.92 13.39 12.90 Other Current Assets 656.44 33.09 44.91 57.43 461.61 291.22 639.08 580.44 502.66 461.34 Short Term Loans & Adv. 627.07 590.16 277.09 243.00 415.66 272.33 605.85 567.50 488.30 458.83 Net Current Assets 1,290.40 985.12 973.58 869.45 1,207.33 759.88 806.97 772.10 513.68 384.94 Total Assets 5,033.48 4,677.04 4,098.09 3,069.12 2,572.46 2,016.91 2,329.31 2,226.48 2,086.29 2,013.74

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 884.03 789.03 628.64 147.10 335.43 271.95 192.63 115.87 177.58 170.87 PBT 877.11 738.34 527.04 471.29 593.71 339.56 269.28 179.04 216.78 230.69 Adjustment 194.07 187.26 202.82 97.05 -56.41 15.19 26.87 14.73 10.01 -9.63 Changes in Working Capital 5.70 -8.64 -12.62 -294.12 -61.45 4.34 -42.44 -39.95 -0.30 1.15 Cash after chg. in Working capital 1,076.87 916.96 717.24 274.22 475.85 359.10 253.70 153.82 226.50 222.22 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -192.84 -127.93 -88.59 -127.12 -140.41 -87.15 -61.08 -37.95 -48.91 -51.34 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -289.93 -412.45 -955.88 4.18 -230.68 23.80 -27.93 -23.97 -42.45 -51.69 Net Fixed Assets -104.26 -247.88 -761.82 -681.80 -12.39 -94.42 -29.82 -29.56 -152.86 -187.76 Net Investments 43.26 -192.30 -193.24 665.16 -274.62 53.26 -22.80 -22.92 67.89 -14.16 Others -228.93 27.73 -0.82 20.82 56.33 64.96 24.69 28.51 42.52 150.23 Cash from Financing Activity -574.27 -374.08 343.41 -137.85 -86.90 -305.48 -155.66 -59.44 -164.84 -97.46 Net Cash Inflow / Outflow 19.84 2.50 16.17 13.42 17.86 -9.73 9.05 32.45 -29.71 21.72 Opening Cash & Equivalents 56.37 53.88 37.69 24.26 6.37 16.11 7.09 -25.36 4.35 -14.50 Closing Cash & Equivalent 76.21 56.37 53.88 37.69 24.26 6.37 16.11 7.09 -25.36 7.23

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 902.45 800.61 625.61 170.13 314.78 275.75 194.33 122.92 201.13 140.41 PBT 887.39 751.51 555.23 504.90 596.89 348.89 286.99 193.95 229.94 212.23 Adjustment 208.56 187.22 195.78 102.27 -46.17 7.95 23.72 16.91 13.11 -1.40 Changes in Working Capital 7.17 -5.64 -29.92 -302.42 -94.21 9.70 -51.47 -47.07 5.92 -16.96 Cash after chg. in Working capital 1,103.12 933.10 721.09 304.75 456.50 366.55 259.24 163.79 248.97 193.88 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -200.67 -132.49 -95.48 -134.62 -141.72 -90.80 -64.91 -40.87 -47.84 -53.47 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -295.90 -403.83 -961.79 2.32 -230.68 23.93 -27.67 -20.68 -45.31 -27.62 Net Fixed Assets -104.26 -247.88 -761.82 -681.80 -12.39 -94.42 -29.82 -29.56 -152.86 -187.76 Net Investments 43.26 -192.30 -193.24 665.16 -274.62 53.26 -22.80 -22.92 67.89 -14.16 Others -234.90 36.35 -6.73 18.96 56.33 65.09 24.95 31.80 39.66 174.30 Cash from Financing Activity -579.67 -385.49 356.54 -138.39 -87.42 -306.05 -155.74 -59.52 -183.84 -99.62 Net Cash Inflow / Outflow 26.88 11.30 20.36 34.07 -3.31 -6.38 10.92 42.72 -28.02 13.17 Opening Cash & Equivalents 88.22 76.93 56.54 22.47 25.75 32.14 21.24 -21.47 6.54 -5.46 Closing Cash & Equivalent 115.09 88.22 76.93 56.54 22.47 25.75 32.14 21.24 -21.47 9.42

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 206.14 176.97 149.97 132.05 233.75 187.02 185.02 173.91 163.62 144.15 ROA 13.69% 12.62% 11.09% 13.04% 19.65% 12.36% 7.99% 5.92% 8.43% 10.38% ROE 21.91% 21.45% 17.83% 18.77% 27.50% 18.30% 12.39% 9.01% 13.25% 16.01% ROCE 26.83% 25.13% 22.02% 24.04% 36.33% 22.96% 18.30% 12.50% 15.65% 19.14% Fixed Asset Turnover 1.38 1.30 1.39 1.54 1.71 1.55 1.51 1.29 1.46 1.86 Receivable days 65.80 61.31 63.54 72.64 69.29 71.64 72.99 82.25 80.81 80.55 Inventory Days 44.07 45.28 44.94 51.19 49.29 48.96 46.67 48.83 44.65 41.01 Payable days 104.38 91.06 73.57 88.41 92.13 39.24 32.65 32.75 29.00 27.03 Cash Conversion Cycle 5.48 15.53 34.91 35.42 26.45 81.36 87.01 98.33 96.46 94.52 Total Debt/Equity 0.00 0.12 0.23 0.01 0.01 0.02 0.02 0.02 0.04 0.14 Interest Cover 97.20 19.22 16.36 96.24 83.55 108.34 59.98 53.45 44.35 23.41

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 209.75 179.35 152.42 134.02 234.17 185.75 184.47 172.50 160.77 139.57 ROA 13.58% 12.60% 11.44% 13.69% 19.55% 12.53% 8.52% 6.43% 8.99% 9.21% ROE 21.81% 21.49% 18.51% 19.89% 27.64% 18.69% 13.28% 9.89% 14.48% 14.80% ROCE 26.73% 25.23% 22.79% 25.48% 36.53% 23.71% 19.59% 13.70% 16.87% 17.72% Fixed Asset Turnover 1.40 1.32 1.46 1.63 1.73 1.57 1.54 1.35 1.53 1.82 Receivable days 67.54 63.93 63.16 69.29 65.62 67.22 67.63 73.15 71.84 79.28 Inventory Days 46.37 47.24 46.91 55.55 55.59 53.31 50.81 53.43 51.77 50.12 Payable days 106.33 91.86 72.35 89.07 92.33 38.74 32.21 33.66 32.86 32.45 Cash Conversion Cycle 7.58 19.31 37.72 35.77 28.88 81.79 86.23 92.93 90.75 96.95 Total Debt/Equity 0.00 0.13 0.23 0.01 0.02 0.02 0.02 0.02 0.04 0.16 Interest Cover 76.66 17.95 16.40 99.60 83.43 108.09 62.74 56.54 43.81 20.80

Top Investors:

kotak midcap fund

axis mutual fund trustee limited a/c axis mutual fund a/c axis small cap fund

nippon life india trustee ltd-a/c nippon india pharma fund

canara robeco mutual fund a/c canara robeco small cap fund

government pension fund global

franklin india small cap fund

tata aia life insurance company ltd - non unit linked life policy holders fund participating

investor education and protection fund (iepf)

Annual Reports:

News Update:

JB Chem & Pharma - Quarterly Results
12th Nov 2025, 00:00 AM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback